Syndax Pharmaceuticals (SNDX) Cash flow

914 Followers

Syndax Pharmaceuticals Cash Flow

SNDX's free cash flow for Q4 2025 was $-69.54M. For the 2025 fiscal year, SNDX's free cash flow was decreased by $-48.26M and operating cash flow was $-69.49M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -322.98M	$ -274.90M	$ -160.60M	$ -133.68M	$ 29.13M
Investing Cash Flow	$ 290.04M	$ -219.78M	$ 117.61M	$ -186.19M	$ -40.87M
Financing Cash Flow	$ 13.68M	$ 353.37M	$ 264.13M	$ 172.25M	$ 118.46M
End Cash Position	$ 135.03M	$ 154.30M	$ 295.61M	$ 74.47M	$ 222.08M
Free Cash Flow	$ -323.17M	$ -274.90M	$ -160.60M	$ -133.90M	$ 29.00M

Currency in USD